osthol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, X; Guo, G; Liang, G; Wang, O; Xiang, Y; Yin, C; Zhang, X; Zhang, Y; Zhao, C | 1 |
1 other study(ies) available for osthol and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Osthole inhibits triple negative breast cancer cells by suppressing STAT3.
Topics: Animals; Apiaceae; Apoptosis; Coumarins; Female; Humans; Mice; STAT3 Transcription Factor; Triple Negative Breast Neoplasms | 2018 |